ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

MTNB Matinas Biopharma Holdings Inc

0.27
0.0024 (0.90%)
Last Updated: 13:31:39
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Matinas Biopharma Holdings Inc MTNB AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0024 0.90% 0.27 13:31:39
Open Price Low Price High Price Close Price Prev Close
0.2627 0.2627 0.273 0.2676
more quote information »

Recent News

Date Time Source Heading
2/28/20242:47IHNWFeatured1606 Corp. Recaps Major Accomplishments in February & Provides Outlook For March
2/28/20241:54IHNWFeaturedBusiness Update from John Kim New CEO at Volcon Inc
2/28/20241:38IHNWFeaturedFirst Graphene (OTCQB: FGPHF) Extending the Commercialization of PureGraph
2/26/202408:05EDGAR2Form 8-K - Current report
2/26/202408:00GLOBEMatinas BioPharma Provides Positive Outcomes Update on the..
2/20/202407:35EDGAR2Form 8-K - Current report
2/20/202407:30GLOBEMatinas BioPharma Successfully Reaches Agreement with FDA..
1/09/202407:30EDGAR2Form 8-K - Current report
1/03/202407:00GLOBEMatinas BioPharma to Present at Biotech Showcase 2024
12/27/202307:40EDGAR2Form 8-K - Current report
12/27/202307:30GLOBEMatinas BioPharma Demonstrates in vivo Biological Activity..
12/21/202307:40EDGAR2Form 8-K - Current report
12/21/202307:30GLOBEMatinas BioPharma Provides Update to MAT2203 Regulatory and..
12/15/202321:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202321:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202321:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202321:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202321:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202321:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/20/202307:30EDGAR2Form 8-K - Current report
11/09/202317:25EDGAR2Form 8-K - Current report
11/08/202316:06EDGAR2Form 8-K - Current report
11/08/202316:05GLOBEMatinas BioPharma Reports Third Quarter 2023 Financial..
11/08/202316:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202307:30GLOBEMatinas BioPharma Announces Positive in vivo Efficacy..
11/03/202316:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/02/202317:20EDGAR2Form 8-K - Current report
11/01/202307:00GLOBEMatinas BioPharma to Webcast Conference Call to Discuss..
10/11/202310:25APSBiotech Catches Massive Premarket Bid
10/11/202307:30GLOBEPatient with Candida krusei Infection in Matinas BioPharma’s..
9/28/202307:00GLOBEMatinas BioPharma to Present at Two Investment Conferences..
9/27/202307:00GLOBEMatinas BioPharma to Feature MAT2203 in a Pipeline..
9/22/202317:25EDGAR2Form 8-K - Current report
9/22/202317:25GLOBEMatinas BioPharma Announces Notification of NYSE American..
9/21/202309:35GLOBEDawson James Securities Announces October Date for 8th..
9/20/202307:30EDGAR2Form 8-K - Current report
9/19/202317:25EDGAR2Form DEF 14A - Other definitive proxy statements
9/08/202317:15EDGAR2Form PRE 14A - Other preliminary proxy statements
9/06/202307:00GLOBEMatinas BioPharma to Participate in the H.C. Wainwright..
8/22/202307:30GLOBEMatinas BioPharma Announces Publication of Results from the..
8/09/202316:06EDGAR2Form 8-K - Current report
8/09/202316:05GLOBEMatinas BioPharma Reports Second Quarter 2023 Financial..
8/09/202316:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/02/202307:00GLOBEMatinas BioPharma to Participate in the BTIG Virtual..
7/26/202308:00GLOBEMatinas BioPharma to Webcast Conference Call to Discuss..
7/07/202317:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
5/11/202307:30GLOBEMatinas BioPharma to Present at the JMP Securities Life..
5/10/202316:05GLOBEMatinas BioPharma Reports First Quarter 2023 Financial..
5/03/202307:00GLOBEMatinas BioPharma to Webcast Conference Call to Discuss..
4/18/202308:00GLOBECompassionate Use Patient Treated with Matinas BioPharma’s..
3/15/202316:05GLOBEMatinas BioPharma Reports 2022 Financial Results and..
3/08/202307:00GLOBEMatinas BioPharma to Webcast Conference Call to Discuss 2022..
3/02/202307:00GLOBEMatinas BioPharma Announces that MAT2203 Will Be Featured in..

Your Recent History

Delayed Upgrade Clock